Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017 by Bob Yirka, Medical Xpress report
High magnification micrograph of hypertrophic decidual vasculopathy, as seen in pregnancy-induced hypertension. Credit: Wikipedia

(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by high blood pressure and kidney problems. In their paper published in the journal Science, the team describes how they studied the hormone elabela in pregnant mice and their hope that their findings may lead to a treatment for preeclampsia in humans.

Preeclampsia is a very serious ailment for pregnant women—their rises quickly and dramatically and they experience buildup of a protein in their urine. Fortunately, the condition is not very common, occurring in just 5 to 8 percent of all pregnancies. But if not treated quickly, it can be fatal. In this new effort, the researchers report that they were studying the elabela to learn more about what it does in both mammals and fish. They found that the hormone was typically present in the placenta and in the bloodstreams of pregnant mice.

After wondering what might happen if the hormone were absent during pregnancy, they genetically altered some test mice and then observed what happened as they became pregnant. They report that the absence of the hormone resulted in vascular abnormalities in developing embryos and in placentas—both symptoms common with preeclampsia. That prompted the team to take a closer look at what was occurring—RNA analysis of placentas that lacked the hormone showed that suggested hypoxia conditions, which included expressions, prior research has shown, that are part of the blood vessel building process—another symptom common in women with preeclampsia. The group also tested the genetically altered and found that they had abnormal levels of protein in their urine and heightened blood pressure levels. Additionally, their pups were underweight—all symptoms of preeclampsia.

Excited by their findings, the team injected the hormone, replacing what had been lost, into the impacted test mice and found that their preeclampsia symptoms disappeared almost immediately. It is not clear if the same hormone, or lack of it, might play a role in preeclampsia in humans, but the team hopes to find out. If the work is transferable, it might finally provide a means for spotting a tendency toward for pregnant women, and possibly warding off the condition altogether.

Explore further: Increases in sFLT1 predict the onset of preeclampsia symptoms in mice

More information: Lena Ho et al. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice, Science (2017). DOI: 10.1126/science.aam6607

Pre-eclampsia (PE) is a gestational hypertensive syndrome affecting between 5 and 8% of all pregnancies. While PE is the leading cause of fetal and maternal morbidity/mortality, its molecular etiology is still unclear. Here, we show that ELABELA (ELA), an endogenous ligand of the apelin receptor (APLNR, or APJ), is a circulating hormone secreted by the placenta. Elabela but not Apelin knockout pregnant mice exhibit PE-like symptoms, including proteinuria and elevated blood pressure due to defective placental angiogenesis. In mice, infusion of exogenous ELA normalizes hypertension, proteinuria, and birth weight. ELA, which is abundant in human placentas, increases the invasiveness of trophoblast-like cells, suggesting that it enhances placental development to prevent PE. The ELA-APLNR signaling axis may offer a new paradigm for the treatment of common pregnancy-related complications, including PE.

Related Stories

Increases in sFLT1 predict the onset of preeclampsia symptoms in mice

June 6, 2016
Preeclampsia is a life-threatening pregnancy complication associated with high blood pressure and increased sensitivity to angiotensin II, a hormone that elevates blood pressure.

Potential treatment for pregnant women who suffer from preeclampsia found in a vitamin

December 15, 2016
Scientists in Japan and the US have found that vitamin B3 nicotinamide may help treat pregnant women who suffer from preeclampsia by preventing strokes and in some cases, even stimulating the growth of their fetus.

Stroke risk factors for pregnant women with preeclampsia uncovered

May 25, 2017
Women with preeclampsia, a common complication of pregnancy, face a heightened risk of stroke during pregnancy and postpartum if they have urinary tract infections, chronic high blood pressure, or clotting or bleeding disorders, ...

Screening for preeclampsia in pregnant women recommended

April 25, 2017
The U.S. Preventive Services Task Force (USPSTF) recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy. The report appears in the April 25 issue of JAMA.

Pre-pregnancy heart abnormalities may predict recurrent preeclampsia risk

February 22, 2016
Women who had pregnancy-related high blood pressure multiple times had recognizable heart abnormalities between pregnancies that could help predict their risk for heart and blood vessel disease during subsequent pregnancies ...

New biomarker predicts development of preeclampsia at six weeks of pregnancy

November 23, 2015
Preeclampsia is generally diagnosed later in pregnancy, but new research could lead to diagnosis in the first trimester, improving care and potentially leading to the development of preventative measures.

Recommended for you

Rise in preterm births linked to clinical intervention

January 18, 2018
Research at the University of Adelaide shows preterm births in South Australia have increased by 40 percent over 28 years and early intervention by medical professionals has resulted in the majority of the increase.

New report calls into question effectiveness of pregnancy anti-nausea drug

January 17, 2018
Previously unpublished information from the clinical trial that the U.S. Food and Drug Administration relied on to approve the most commonly prescribed medicine for nausea in pregnancy indicates the drug is not effective, ...

New study finds 'baby brain' is real, but the cause remains mysterious

January 15, 2018
So-called "baby brain" refers to increased forgetfulness, inattention, and mental "fogginess" reported by four out of five pregnant women. These changes in brain function during pregnancy have long been recognised in midwifery ...

Sleep quality improves with help of incontinence drug

January 12, 2018
A drug used to curtail episodes of urinary incontinence in women also improves quality of sleep, a researcher at the Stanford University School of Medicine reports.

Frozen embryos result in just as many live births in IVF

January 10, 2018
Freezing and subsequent transfer of embryos gives infertile couples just as much of a chance of having a child as using fresh embryos for in vitro fertilization (IVF), research from Ho Chi Minh City, Vietnam, and Adelaide, ...

Study suggests air pollution breathed in the months before and after conception increases chance of birth defects

January 8, 2018
A team of researchers with the University of Cincinnati and Cincinnati Children's Hospital has found evidence that indicates that pre-and post-pregnant women living in an area with air pollution are at an increased risk of ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jun 30, 2017
Does these mice' pre-eclampsia respond to magnesium supplements as in the human model ??
not rated yet Jul 03, 2017
I remember seeing report that this is caused by nutrient deficiency as proved by English doctor years ago. But because there is no money in supplements, the industry has ignored his research. The above news makes sense since missing hormone might need some nutrients to be present.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.